Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences

Olivier Gires1, Nikolas H Stoecklein

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377, Munich, Germany, olivier.gires@med.uni-muenchen.de.

Summary

Detecting circulating tumor cells (CTCs) is crucial for cancer metastasis. This review explores why the epithelial marker EpCAM expression changes, impacting CTC detection during cancer progression.